Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison B Goldfine

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Circulation|December 11, 2020
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA TherapyChintan V Dave, Seoyoung C Kim, Allison B Goldfine, et al.
Annals of Internal Medicine|March 17, 2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trialAllison B Goldfine, Vivian Fonseca, Kathleen A Jablonski, et al.
Clinical and Translational Science|April 2, 2009
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetesAllison B Goldfine, Robert Silver, Waleed Aldhahi, et al.
Frontiers in Immunology|November 26, 2024
Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical developmentCharlotte Hagman, Gaetan Chasseigne, Robert Nelson, et al.
Obesity (Silver Spring, Md.)|February 24, 2006
Acute insulin secretion as a predictor of weight gain in healthy humansRobert J Silver, Sheena Mehta, J Stuart Soeldner, et al.
JACC. Cardiovascular Imaging|August 14, 2010
Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imagingThomas Christen, Yuri Sheikine, Viviane Z Rocha, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2003
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitusJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Atherosclerosis|February 20, 2022
The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacityBela F Asztalos, Thomas H Hauser, Allison B Goldfine, et al.
BMJ (Clinical Research Ed.)|February 14, 2018
Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort studyElisabetta Patorno, Allison B Goldfine, Sebastian Schneeweiss, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Circulation|December 11, 2020
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA TherapyChintan V Dave, Seoyoung C Kim, Allison B Goldfine, et al.
Annals of Internal Medicine|March 17, 2010
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trialAllison B Goldfine, Vivian Fonseca, Kathleen A Jablonski, et al.
Clinical and Translational Science|April 2, 2009
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetesAllison B Goldfine, Robert Silver, Waleed Aldhahi, et al.
Frontiers in Immunology|November 26, 2024
Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical developmentCharlotte Hagman, Gaetan Chasseigne, Robert Nelson, et al.
Obesity (Silver Spring, Md.)|February 24, 2006
Acute insulin secretion as a predictor of weight gain in healthy humansRobert J Silver, Sheena Mehta, J Stuart Soeldner, et al.
JACC. Cardiovascular Imaging|August 14, 2010
Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imagingThomas Christen, Yuri Sheikine, Viviane Z Rocha, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 26, 2003
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitusJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Atherosclerosis|February 20, 2022
The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacityBela F Asztalos, Thomas H Hauser, Allison B Goldfine, et al.
BMJ (Clinical Research Ed.)|February 14, 2018
Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort studyElisabetta Patorno, Allison B Goldfine, Sebastian Schneeweiss, et al.
Pageof 14